Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action

Name: Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action
SKU: 4223
Availability: InStock

$30.00

ORIGINAL RESEARCH

Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action

By Andrew C. Leon

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 42 No. 2 Articles Tags: andrew-c-leon, attrition, cure-model, multiplicity, onset-of-action, original-research, randomized-controlled-clinical-trials

Description

Description

ORIGINAL RESEARCH

Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action

By Andrew C. Leon

Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action

Description

Recent-Onset Schizophrenia and Adolescent Cannabis Use: MRI Evidence for Structural Hyperconnectivity?

Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)

A Pilot Study of the Pharmacodynamic Impact of SSRI Drug Selection and Beta-1 Receptor Genotype (ADRB1) on Cardiac Vital Signs in Depressed Patients: A Novel Pharmacogenetic Approach

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action

Description

Related products

Recent-Onset Schizophrenia and Adolescent Cannabis Use: MRI Evidence for Structural Hyperconnectivity?

Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)

A Pilot Study of the Pharmacodynamic Impact of SSRI Drug Selection and Beta-1 Receptor Genotype (ADRB1) on Cardiac Vital Signs in Depressed Patients: A Novel Pharmacogenetic Approach

Quetiapine XR Negative Clinical Trials Report by Gang Wang